Newsroom
Find the latest information about our products

Kinase Logistics Europe News

  • Next-generation Mobility Shift Assay Detection System! General

    Next-generation Mobility Shift Assay Detection System!

    We have great News for you: MSA is still accessible to your drug discovery research!
     

    Read more
  • Biotinylated Kinases General

    Biotinylated Kinases

    We’ve new products for you: biologically biotinylated human Kinases from Carna Biosciences.

    Read more
  • New Cellular CDK Assay Panel Launched and Special Offers from Carna Offers

    New Cellular CDK Assay Panel Launched and Special Offers from Carna

    We are pleased to launch a new CDK (cyclin-dependent kinases) Cell-based Assay Panel for kinase researchers who are focusing on the CDK family.

    Read more
  • New Website Launch! General

    New Website Launch!

    We’re extremely pleased to announce the launch of our new website!

    We decided that it was time for a fresh new look, which surely empowers our…

    Read more
  • First
  • «
  • 1
  • »
  • Last

Carna Biosciences Newsletter

  • Newsletter

    Cancer treatments using inhibitors of CDK, a cell cycle regulator

    Carna Newsletter Vol.16

    Read more
  • Newsletter

    ALK drug resistant mutations: Challenges for the treatment of lung cancer

    Carna Newsletter Vol.15 

     

    Read more
  • Technical Note

    DGKα and DGKζ are key targets for cancer immunotherapy

    Carna Newsletter Vol.14

    Read more
  • Newsletter

    The potential of PIKfyve inhibitor as a treatment of amyotrophic lateral sclerosis (ALS)

    Carna Newsletter Vol.13

    Read more
  • Newsletter

    The importance of understanding the activity of compounds on RAF dimerization in BRAF inhibitor drug discovery

    Carna Biosciences Newsletter Vol. 12

    Read more
  • Newsletter

    Kinase Inhibitors as Potential Therapeutic Agents for COVID-19

    Carna Biosciences Newsletter Vol. 11

    Read more
  • Technical Note

    Evaluating Kinase Inhibitors in Binding Assays using Activated and Non-Activated Biotinylated Kinases

    Carna Biosciences Technical Note No. 1

    Read more
  • Newsletter

    Targeted Degradation of Non-catalytic Kinases New Drug Discovery Options

    Carna Biosciences Newsletter Vol. 10

    Read more
  • Newsletter

    Drug-resistant EGFR mutations in lung cancer

    Carna Biosciences Newsletter Vol. 9

    Read more
  • Newsletter

    Kinetic analysis of covalent and irreversible inhibitors

    Carna Biosciences Newsletter Vol. 8

    Read more
  • Technical Note

    The importance of assessing intrinsic target kinase activity

    Carna Biosciences Technical Note No. 2

    Read more
  • Technical Note

    Production of Highly Active Protein Kinases for Drug Discovery Applications

    Carna Biosciences Technical Note No. 1

    Read more
  • Newsletter

    Kinase Inhibitors in the Fight against COVID-19

    Carna Biosciences Newsletter Vol. 7

    Read more
  • Newsletter

    Recommendations for off-target profiling

    Carna Biosciences Newsletter Vol. 6

    Read more
  • Newsletter

    The significance of ATP concentration in cell-free and cell-based assays

    Carna Biosciences Newsletter Vol. 4

    Read more
  • Newsletter

    Targeted Protein Degraders

    Carna Biosciences Newsletter Vol. 3

    Read more
  • Newsletter

    Residence time and compound selectivity

    Carna Biosciences Newsletter Vol. 2

    Read more
  • Newsletter

    A story about biotin-avidin affinity and how it accelerates small molecule drug discovery

    Carna Biosciences Newsletter Vol. 1

    Read more
  • First
  • «
  • 1
  • 2
  • 3
  • »
  • Last
Scientist typing on Laptop

Newsletter

Newsletter abonnieren Icon
Contact us